{"name":"Aphaia Pharma US LLC","slug":"aphaia-pharma-us-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"immunology","drugs":[{"name":"APH-012P","genericName":"APH-012P","slug":"aph-012p","indication":"Type 2 diabetes","status":"phase_2"},{"name":"APHP-002","genericName":"APHP-002","slug":"aphp-002","indication":"Type 2 diabetes","status":"phase_2"},{"name":"APHD-012","genericName":"APHD-012","slug":"aphd-012","indication":"Type 2 diabetes","status":"phase_2"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"APHP-012","genericName":"APHP-012","slug":"aphp-012","indication":"Other","status":"phase_2"},{"name":"APHD-012P","genericName":"APHD-012P","slug":"aphd-012p","indication":"Other","status":"phase_2"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"APHD-002","genericName":"APHD-002","slug":"aphd-002","indication":"Type 2 diabetes","status":"phase_2"}]}],"pipeline":[{"name":"APHP-012","genericName":"APHP-012","slug":"aphp-012","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"APH-012P","genericName":"APH-012P","slug":"aph-012p","phase":"phase_2","mechanism":"APH-012P is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"APHP-002","genericName":"APHP-002","slug":"aphp-002","phase":"phase_2","mechanism":"APHP-002 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"APHD-012","genericName":"APHD-012","slug":"aphd-012","phase":"phase_2","mechanism":"APHD-012 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"APHD-002","genericName":"APHD-002","slug":"aphd-002","phase":"phase_2","mechanism":"APHD-002 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes","Cardiovascular risk reduction in patients with type 2 diabetes"],"catalyst":""},{"name":"APHD-012P","genericName":"APHD-012P","slug":"aphd-012p","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxNZjVyUVRCNTZDcUxOYlNzd1dRSWZrUE1Qdlh1cEVNY2VHT0c0YU93U1ZuVnpCbzBlMDBkcUxGeHlFbktQbmhaQmpLOGF4bm92cDUxbHpTLUtlbzJ2amVnVy1ieXlsWElUcDRWQ0pYc1Q1N2c1R3hzS1lGcTM4R3dIV1hyTS1Ma0JCRlc5MGduX3V0REYxOVN3QmUwSVFReUVVX3VaUUV3SUJsTGlZTzYtZmFua0NIUnprUmp1V1N0amtUOHNzMTZPbEdQQkhpZ3NnYVI3cENlY25CcXktR3dmaFR0aGIzUExRaE95WmYwRzk1b0kzenNaLWVRMVk5Zw?oc=5","date":"2025-02-27","type":"pipeline","source":"globenewswire.com","summary":"WEGOVY Marks Significant Growth in Market Share Across the 7MM for Obesity Treatment | DelveInsight - globenewswire.com","headline":"WEGOVY Marks Significant Growth in Market Share Across the 7MM for Obesity Treatment | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AJBVV95cUxOdk1PTWZqbnlNeDRkQU0ycWl0ZUxsdUZ4MjVubTlsZ1BKX3hSdFR4VU1Wc2lqMDZoRkFiWTA5MXB0OE1QSG5jcTYtVGV0cGRGb2YydktJLVlGRDZEbmhpY043OWJxaG9ub2xmNDJyQ1J2bEh1VHozYlh0OGV0WmJXRmZTTTVsRmdYR01TQW1SdWhsTFlMMFJYODItMFN6dVhlZS1YQW9IRzFNLWlQN3ZxOXhYQ0VYWWNsRmRqS2IzdzBJenkxc2xoWFRzN0h0Z3pWbUs1LVlzUnVkVm4xZXp4N3JwelFXRHpFM1JWSENKYmNEM2laX2hBYzBBSC02UUI4b0QxMEZkUHpLM25iM1Y2NXNzOHJORzJlSkxoaUxmbFQ4SERNdGcwYnY2cEJXRkFNXzU4NlQ5akY0LWFOakotWmhlcGhXVVY5NUc3ZmhmclZuUjZqbTFFakFSNWxHNWxOSTJHTkFpdlUwajQxRkRzUw?oc=5","date":"2024-06-18","type":"pipeline","source":"PR Newswire","summary":"Obesity Market to Observe Impressive Growth by 2034, Assesses DelveInsight | Key Companies - Novo Nordisk A/S, Pfizer, Boehringer Ingelheim, Eli Lilly and Company, Rhythm Pharmaceuticals, Harmony Bios","headline":"Obesity Market to Observe Impressive Growth by 2034, Assesses DelveInsight | Key Companies - Novo Nordisk A/S, Pfizer, B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNRVg1dmpfNElBVzhlUHpfOUdNWmJPQktvZkRaamNJMjBsT0xwdU1LM1QxcV90OUJDNGpaS19Eb0p6aHhDRHJ3cnh3elMxNVNzNGJZOEhFdzJ6SG14Z2lVZXdBZDJpTzZrMzBqX3pWbEEwVVQxS0hxUTdPYXFYci1Ld185ek9SQ2E1bUFNQVlYenR0c1MwUDdQTmJoak5IdVMzTjhvZ2lqRFE0RjVzaElUME9TTVc?oc=5","date":"2024-03-19","type":"pipeline","source":"Fierce Biotech","summary":"The obesity pipeline was 'late breaking.' Here's what the R&D landscape looks like now - Fierce Biotech","headline":"The obesity pipeline was 'late breaking.' Here's what the R&D landscape looks like now","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxQcmdVa09qQm9JLTluaXNrTWVPRmNzZW1rdTJSeXRmT1RrQmxZU1NsLWx5Z2FsbWpyc1pLUEtRQ29kdHlKZ0g1U284dEpZZF9LRUliSk1Pa1pWSWFlbndVQmtsMy1kOURpY1psWXRZanRvc2NjdFRUZzJhUjFsRjZOWkdrX2FBbEJhWnJuS2pYbTRXLWlGY3RRbEg4aS01SHpPb0RRWGh3akVBZlN4QmpXNzZmNWxqYV9zNjlmSFVqRkFRck9Nck5lNFk1WFU2OEE3VmRTcW13?oc=5","date":"2023-07-07","type":"pipeline","source":"reuters.com","summary":"Biotech firms target weight-loss drugs without Wegovy's side-effects - reuters.com","headline":"Biotech firms target weight-loss drugs without Wegovy's side-effects","sentiment":"neutral"}],"patents":[],"drugCount":6,"phaseCounts":{"phase_2":6},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}